Lopressor injection/adult indications and dosage

Revision as of 02:22, 21 March 2014 by Gerald Chi (talk | contribs) (Created page with "__NOTOC__ {{ {{BASEPAGENAME}} }} {{CMG}} ===FDA-Labeled Indications and Dosage (Adult)=== ====Myocardial Infarction==== * Upon patient presentation: '''''Lopressor inject...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Lopressor injection/adult indications and dosage®
Black Box Warning
Adult Indications and Dosage
Pediatric Indications and Dosage
Contraindications
Warnings
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration and Monitoring
IV Compatibility
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient information
Precautions with Alcohol
Look-Alike Drug Names
Drug Shortage Status
Price

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

FDA-Labeled Indications and Dosage (Adult)

Myocardial Infarction

  • If unable to tolerate the full IV dose: Lopressor tablet 25—50 mg PO q6h for 2 days

Lopressor injection is indicated in the treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality when used in conjunction with oral Lopressor maintenance therapy. Treatment with Lopressor injection can be initiated as soon as the patient’s clinical condition allows.

Off-Label Use and Dosage (Adult)

References